{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T05:24:53.185514+00:00","company":{"ticker":"AZTA","cik":933974,"company_name":"Azenta, Inc."},"pagination":{"limit":100,"returned":16,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"earnings_release","fact_key":"540b7886b92861ad72d8a377456330f42f6c3379","cik":933974,"ticker":"AZTA","company_name":"Azenta, Inc.","filed_at":"2026-05-05T23:59:59+00:00","payload":{"eps_text":"($3.41)","guidance_signal":"lowered","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the fiscal quarter ended March 31, 2026","report_date":"2026-05-05","result_type":"reported_results","revenue_text":"$145 million"},"claim":"Azenta, Inc. reported the fiscal quarter ended March 31, 2026 results: revenue $145 million, EPS ($3.41). Guidance lowered.","evidence_excerpt":"position Azenta for improved execution, greater consistency, and profitable long‐term value creation.” Second Quarter Fiscal 2026 Results - Continuing Operations • Revenue was $145 million, up 1% year over year. Organic revenue, which excludes a 3-percentage point impact from foreign exchange and a 1-percentage point from the acquisition of UK Biocentre Limited,","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-26-030677","anchor_url":"https://secwatch.observer/filing/0001628280-26-030677#claim-540b7886b92861ad72d8a377456330f42f6c3379","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/933974/000162828026030677/0001628280-26-030677-index.htm"},{"fact_type":"material_agreement","fact_key":"09c96582babc14ce62d36d0c07f231c073bca4e8","cik":933974,"ticker":"AZTA","company_name":"Azenta, Inc.","filed_at":"2026-03-04T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Share Purchase Agreement","agreement_type":"asset_purchase","counterparty":"UK Biocentre Limited","effective_date":"2026-03-04","item_codes_triggered":["1.01"],"value_text":"GBP 20.5 million"},"claim":"Azenta, Inc. entered into Share Purchase Agreement with UK Biocentre Limited valued at GBP 20.5 million (effective 2026-03-04).","evidence_excerpt":"On March 4, 2026, Azenta UK Ltd., a wholly owned subsidiary of Azenta, Inc. (“Azenta” or the “Company”) entered into a definitive Share Purchase Agreement (“Agreement”) under which Azenta UK Ltd. acquired all the issued and outstanding share capital of UK Biocentre Limited (“UK Biocentre”), a provider of sample management, sample storage and high-throughput sample processing services in the United Kingdom.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-26-006821","anchor_url":"https://secwatch.observer/filing/0001437749-26-006821#claim-09c96582babc14ce62d36d0c07f231c073bca4e8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/933974/000143774926006821/0001437749-26-006821-index.htm"},{"fact_type":"material_agreement","fact_key":"b4d6beac0627f49b7dfc313965e84f7bcb9de92a","cik":933974,"ticker":"AZTA","company_name":"Azenta, Inc.","filed_at":"2025-12-29T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Share Purchase Agreement","agreement_type":"asset_purchase","counterparty":"Thelema S.À R.L.","effective_date":"2025-12-23","item_codes_triggered":["1.01"],"value_text":"USD 63,000,000"},"claim":"Azenta, Inc. entered into Share Purchase Agreement with Thelema S.À R.L. valued at USD 63,000,000 (effective 2025-12-23).","evidence_excerpt":"On December 23, 2025, Azenta Germany GmbH, a wholly owned subsidiary of Azenta, Inc. (“Azenta” or the “Company”) entered into a definitive Sale and Purchase Agreement (“Share Purchase Agreement”) with Thelema S.À R.L. (“Thelema”) relating to the entire issued share capital of B Medical Systems S.À R.L. (“B Medical”), a subsidiary of Azenta Germany GmbH.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-25-038787","anchor_url":"https://secwatch.observer/filing/0001437749-25-038787#claim-b4d6beac0627f49b7dfc313965e84f7bcb9de92a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/933974/000143774925038787/0001437749-25-038787-index.htm"},{"fact_type":"executive_change","fact_key":"88b7f78374","cik":933974,"ticker":"AZTA","company_name":"Azenta, Inc.","filed_at":"2025-05-16T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-05-15","interim":false,"role":"Senior Vice President, General Counsel and Secretary","role_category":"general_counsel","successor_name":null,"successor_named":false},"claim":"Ephraim Starr was appointed as Senior Vice President, General Counsel and Secretary at Azenta, Inc..","evidence_excerpt":"On May 15, 2025, the Company appointed Ephraim Starr as its Senior Vice President, General Counsel and Secretary to succeed Mr. Joseph.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-25-017419","anchor_url":"https://secwatch.observer/filing/0001437749-25-017419#claim-88b7f78374","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/933974/000143774925017419/0001437749-25-017419-index.htm"},{"fact_type":"executive_change","fact_key":"a178700fb7","cik":933974,"ticker":"AZTA","company_name":"Azenta, Inc.","filed_at":"2025-05-16T23:59:59+00:00","payload":{"action":"cease to serve","action_category":"departure","departure_tone":"routine","effective_date":"2025-05-15","interim":false,"role":"Senior Vice President, General Counsel and Secretary","role_category":"general_counsel","successor_name":"Ephraim Starr","successor_named":true},"claim":"Jason W. Joseph departed as Senior Vice President, General Counsel and Secretary at Azenta, Inc..","evidence_excerpt":"On May 12, 2025, Azenta, Inc. (the “Company”) and Jason W. Joseph, Senior Vice President, General Counsel and Secretary, agreed that Mr. Joseph would cease to serve in that role, effective May 15, 2025 and that Mr. Joseph’s employment with the Company would cease effective June 30, 2025.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-25-017419","anchor_url":"https://secwatch.observer/filing/0001437749-25-017419#claim-a178700fb7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/933974/000143774925017419/0001437749-25-017419-index.htm"},{"fact_type":"executive_change","fact_key":"33130ad93f","cik":933974,"ticker":"AZTA","company_name":"Azenta, Inc.","filed_at":"2025-04-09T23:59:59+00:00","payload":{"action":"ceased","action_category":"departure","departure_tone":"routine","effective_date":"2025-04-09","interim":false,"role":"President of Sample Management Solutions","role_category":"president","successor_name":null,"successor_named":false},"claim":"David Wang departed as President of Sample Management Solutions at Azenta, Inc..","evidence_excerpt":"On April 7, 2025, Azenta, Inc. (the “Company”) and David Wang, President of Sample Management Solutions, agreed that Mr. Wang’s employment with the Company would cease effective April 9, 2025","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-25-011527","anchor_url":"https://secwatch.observer/filing/0001437749-25-011527#claim-33130ad93f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/933974/000143774925011527/0001437749-25-011527-index.htm"},{"fact_type":"executive_change","fact_key":"2bab6c5e7a","cik":933974,"ticker":"AZTA","company_name":"Azenta, Inc.","filed_at":"2024-11-12T23:59:59+00:00","payload":{"action":"departing","action_category":"departure","departure_tone":"routine","effective_date":null,"interim":false,"role":"Executive Vice President and Chief Financial Officer","role_category":"cfo","successor_name":"Lawrence Lin","successor_named":true},"claim":"Herman Cueto departed as Executive Vice President and Chief Financial Officer at Azenta, Inc..","evidence_excerpt":"Herman Cueto, who is departing from his role at the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-24-034563","anchor_url":"https://secwatch.observer/filing/0001437749-24-034563#claim-2bab6c5e7a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/933974/000143774924034563/0001437749-24-034563-index.htm"},{"fact_type":"executive_change","fact_key":"8cb8170513","cik":933974,"ticker":"AZTA","company_name":"Azenta, Inc.","filed_at":"2024-11-12T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":null,"interim":false,"role":"Executive Vice President and Chief Financial Officer","role_category":"cfo","successor_name":"Herman Cueto","successor_named":true},"claim":"Lawrence Lin was appointed as Executive Vice President and Chief Financial Officer at Azenta, Inc..","evidence_excerpt":"appointed Lawrence Lin as its Executive Vice President and Chief Financial Officer, effective as of Effective Time","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-24-034563","anchor_url":"https://secwatch.observer/filing/0001437749-24-034563#claim-8cb8170513","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/933974/000143774924034563/0001437749-24-034563-index.htm"},{"fact_type":"executive_change","fact_key":"c69814bf2c","cik":933974,"ticker":"AZTA","company_name":"Azenta, Inc.","filed_at":"2024-11-04T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-11-01","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Quentin Koffey was appointed as Director at Azenta, Inc..","evidence_excerpt":"Pursuant to the Cooperation Agreement, on November 1, 2024, the Board appointed Mr. Koffey as a member of the Board, effective November 1, 2024, with an initial term expiring at the 2025 Annual Meeting.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-24-033059","anchor_url":"https://secwatch.observer/filing/0001437749-24-033059#claim-c69814bf2c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/933974/000143774924033059/0001437749-24-033059-index.htm"},{"fact_type":"executive_change","fact_key":"2cb7802053","cik":933974,"ticker":"AZTA","company_name":"Azenta, Inc.","filed_at":"2024-11-04T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-11-01","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Alan Malus was appointed as Director at Azenta, Inc..","evidence_excerpt":"Effective November 1, 2024, the Board appointed each of Mr. Cornog and Mr. Malus (together with Mr. Koffey, the “New Directors”) as a member of the Board, with an initial term expiring at the 2025 Annual Meeting.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-24-033059","anchor_url":"https://secwatch.observer/filing/0001437749-24-033059#claim-2cb7802053","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/933974/000143774924033059/0001437749-24-033059-index.htm"},{"fact_type":"executive_change","fact_key":"df1502c2bc","cik":933974,"ticker":"AZTA","company_name":"Azenta, Inc.","filed_at":"2024-11-04T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-11-01","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"William Cornog was appointed as Director at Azenta, Inc..","evidence_excerpt":"Effective November 1, 2024, the Board appointed each of Mr. Cornog and Mr. Malus (together with Mr. Koffey, the “New Directors”) as a member of the Board, with an initial term expiring at the 2025 Annual Meeting.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-24-033059","anchor_url":"https://secwatch.observer/filing/0001437749-24-033059#claim-df1502c2bc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/933974/000143774924033059/0001437749-24-033059-index.htm"},{"fact_type":"executive_change","fact_key":"911b0fdde8","cik":933974,"ticker":"AZTA","company_name":"Azenta, Inc.","filed_at":"2024-09-04T23:59:59+00:00","payload":{"action":"retiring","action_category":"departure","departure_tone":"retirement","effective_date":"2024-09-09","interim":false,"role":"President and Chief Executive Officer","role_category":"ceo","successor_name":"John Marotta","successor_named":true},"claim":"Stephen Schwartz departed as President and Chief Executive Officer at Azenta, Inc..","evidence_excerpt":"succeed the Company’s current President and Chief Executive Officer, Dr. Stephen Schwartz, who as previously announced is retiring effective as of the Start Date","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-24-028399","anchor_url":"https://secwatch.observer/filing/0001437749-24-028399#claim-911b0fdde8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/933974/000143774924028399/0001437749-24-028399-index.htm"},{"fact_type":"executive_change","fact_key":"019b307aac","cik":933974,"ticker":"AZTA","company_name":"Azenta, Inc.","filed_at":"2024-09-04T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-09-09","interim":false,"role":"Member of the Board","role_category":"director","successor_name":null,"successor_named":false},"claim":"John Marotta was appointed as Member of the Board at Azenta, Inc..","evidence_excerpt":"the Board also increased the size of the Board from eight to nine members and appointed Mr. Marotta as a member of the Board","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-24-028399","anchor_url":"https://secwatch.observer/filing/0001437749-24-028399#claim-019b307aac","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/933974/000143774924028399/0001437749-24-028399-index.htm"},{"fact_type":"executive_change","fact_key":"0a386f12cb","cik":933974,"ticker":"AZTA","company_name":"Azenta, Inc.","filed_at":"2024-05-09T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"retirement","effective_date":"2024-05-07","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Stephen Schwartz resigned as director at Azenta, Inc..","evidence_excerpt":"Dr. Schwartz resigned as a director of the Company effective as of May 7, 2024","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001558370-24-007472","anchor_url":"https://secwatch.observer/filing/0001558370-24-007472#claim-0a386f12cb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/933974/000155837024007472/0001558370-24-007472-index.htm"},{"fact_type":"executive_change","fact_key":"2028374828","cik":933974,"ticker":"AZTA","company_name":"Azenta, Inc.","filed_at":"2024-05-09T23:59:59+00:00","payload":{"action":"retired","action_category":"departure","departure_tone":"retirement","effective_date":null,"interim":false,"role":"President and Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Stephen Schwartz retired as President and Chief Executive Officer at Azenta, Inc..","evidence_excerpt":"Dr. Stephen Schwartz informed the Company of his intention to retire from his position as President and Chief Executive Officer and a director of the Company","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001558370-24-007472","anchor_url":"https://secwatch.observer/filing/0001558370-24-007472#claim-2028374828","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/933974/000155837024007472/0001558370-24-007472-index.htm"},{"fact_type":"earnings_release","fact_key":"b5e1dbd5d1df23a0df49c7f6ac94f5de6f6aec57","cik":933974,"ticker":"AZTA","company_name":"Azenta, Inc.","filed_at":"2024-05-08T23:59:59+00:00","payload":{"eps_text":"$ (2.47) diluted EPS from continuing operations","guidance_signal":"lowered","item_codes_triggered":["2.02"],"net_income_text":"$ (2.47) diluted EPS from continuing operations","period_text":"the fiscal quarter ended March 31, 2024","report_date":"2024-05-08","result_type":"reported_results","revenue_text":"$159 million"},"claim":"Azenta, Inc. reported the fiscal quarter ended March 31, 2024 results: revenue $159 million, net income $ (2.47) diluted EPS from continuing operations, EPS $ (2.47) diluted EPS from continuing operations. Guidance lowered.","evidence_excerpt":"Day in March, we are confident in our position and the market opportunity which we are uniquely positioned to capture.” ​ Second Quarter Fiscal 2024 Results ● Revenue was $159 million, up 7% year over year. Organic revenue, which excludes the impacts from foreign exchange, was also up 7% year over year, with a nominal benefit from foreign exchange tailwinds.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001558370-24-007348","anchor_url":"https://secwatch.observer/filing/0001558370-24-007348#claim-b5e1dbd5d1df23a0df49c7f6ac94f5de6f6aec57","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/933974/000155837024007348/0001558370-24-007348-index.htm"}]}